Folger Nolan Fleming Douglas Capital Management, Inc Abbott Laboratories Transaction History
Folger Nolan Fleming Douglas Capital Management, Inc
- $889 Million
- Q2 2024
A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 101,188 shares of ABT stock, worth $11.5 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
101,188
Previous 103,136
1.89%
Holding current value
$11.5 Million
Previous $11.7 Million
10.31%
% of portfolio
1.18%
Previous 1.31%
Shares
30 transactions
Others Institutions Holding ABT
# of Institutions
3,137Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.43 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.14 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.49 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $198B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...